首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3006篇
  免费   163篇
  国内免费   68篇
耳鼻咽喉   11篇
儿科学   9篇
妇产科学   12篇
基础医学   444篇
口腔科学   50篇
临床医学   178篇
内科学   277篇
皮肤病学   30篇
神经病学   65篇
特种医学   113篇
外国民族医学   1篇
外科学   161篇
综合类   352篇
预防医学   510篇
眼科学   14篇
药学   732篇
  3篇
中国医学   189篇
肿瘤学   86篇
  2023年   28篇
  2022年   92篇
  2021年   132篇
  2020年   64篇
  2019年   80篇
  2018年   82篇
  2017年   98篇
  2016年   116篇
  2015年   106篇
  2014年   201篇
  2013年   325篇
  2012年   208篇
  2011年   211篇
  2010年   155篇
  2009年   142篇
  2008年   120篇
  2007年   111篇
  2006年   113篇
  2005年   88篇
  2004年   94篇
  2003年   83篇
  2002年   59篇
  2001年   42篇
  2000年   40篇
  1999年   39篇
  1998年   36篇
  1997年   32篇
  1996年   32篇
  1995年   25篇
  1994年   27篇
  1993年   20篇
  1992年   31篇
  1991年   24篇
  1990年   14篇
  1989年   18篇
  1988年   17篇
  1987年   12篇
  1986年   11篇
  1985年   16篇
  1984年   15篇
  1983年   11篇
  1982年   14篇
  1981年   14篇
  1980年   5篇
  1979年   9篇
  1978年   9篇
  1977年   4篇
  1976年   5篇
  1975年   3篇
  1970年   2篇
排序方式: 共有3237条查询结果,搜索用时 343 毫秒
91.
The aim of the present work is to study the role of the different forces involved in the agglutination of immune γ-globulin (IgG) covered latex particles due to antigen-antibody reaction. An experimental investigation on the adsorption of IgG molecules on three latexes with different surface charge densities is described. Photon correlation spectroscopy was used to determine the hydrodynamic layer thickness of the IgG molecules adsorbed on the latexes. In order to get an insight into the forces acting between two antibody-covered particles approaching each other, the colloidal stability and immunoreactivity of these biocomplexes were studied. They can be stabilized by electrostatic or hydration forces. The immunological agglutination of IgGimmobilized latex particles due to the addition of the antigen was quantified through scattered light intensity measurements. The immunoresponse increases with ionic strength of the medium until a maximum value is achieved. Above this maximum, the immunoreactivity decreases.  相似文献   
92.
Influenza virus-like particles (VLPs) represent promising alternative vaccines. However, it is necessary to demonstrate that influenza VLPs confer cross-protection against antigenically distinct viruses. In this study, a VLP vaccine comprising hemagglutinin (HA) and M1 from the A/California/04/2009 (H1N1) were used and its ability to induce cross-protective efficacy against heterologous viruses A/PR/8/34 (H1N1) and A/New Caledonia/20/99 (H1N1) in mice was assessed. Vaccination with 2009 H1 VLPs induced significantly higher levels of IgG cross-reactive with these heterologous viruses after the second boost compared to after the prime or first boost. Lung virus titers also decreased significantly and the lung cross-reactive IgG response after lethal virus challenge was significantly greater in immunized mice compared to naïve mice. Vaccinated mice showed 100% protection against A/PR/8/34 and A/Caledonia/20/99 viruses with only moderate body weight loss and induction of cross-reactive recall, IgG antibody-secreting cell responses. The variations in HA amino acid sequences and antigenic sites were determined and correlated with induction of cross-protective immunity. These results indicate that VLPs can be used as an effective vaccine that confers cross-protection against antigenically distinct viruses.  相似文献   
93.
There are several relationships between retroviruses and cellular transformation, as well as retroviruses being involved in the development of autoimmune diseases. Retroviruses have been discussed as etiologic agents modulating or triggering certain pathways in the pathogenesis of rheumatoid arthritis (RA). However, none of the currently known retroviruses has been identified as specific for RA. Due to the unique properties of retroviruses, distinct experimental approaches can be used to detect retroviral activity in cells and tissues. Current research in RA using state-of-the-art molecular biology techniques includes both the search for exogenous and endogenous retroviral gene sequences in synovium of patients with RA.  相似文献   
94.
目的 通过溶胶-凝胶法合成纳米尺径的硅基生物活性颗粒(SBPs),检测其对间充质干细胞(MSCs)成骨分化和迁移的作用。方法 通过溶胶-凝胶法合成SBPs,通过扫描电镜和ZATA电位分析仪检测颗粒的物理特征。在培养基中添加SBPs配置成系列浓度的条件培养基,检测不同浓度的SBPs对小鼠MSCs增殖、成骨分化和迁移的影响。结果 SBPs的平均直径为134.3 nm,并且呈均匀分散球形颗粒。不同浓度的SBPs对MSCs增殖无影响;但4 µg/mL的SBPs对细胞成骨分化有明显的促进作用;高浓度(>16 µg/mL)的SBPs抑制MSCs的成骨分化;4 µg/mL的SBPs对MSCs有明显的促进迁移的作用。结论 在适宜浓度范围内(1 ~ 4 μg/mL),SBPs具有促成骨作用和诱导MSCs迁移,未来可能被用来与其他生物材料复合制备新型的骨移植材料。  相似文献   
95.
The synthesis of polystyrene (PS) brushes on fully deuterated PS nanoparticles by surface‐initiated nitroxide‐mediated radical polymerization (SI‐NMRP) is reported. Due to the high demand of deuterated monomers, an efficient deuteration procedure of suitable and readily available precursors is developed. SI‐NMRP of styrene is improved regarding reaction control, grafting density, and conversion. Insights into the scaling behavior and conformational features of surface‐attached PS chains on deuterated particles are investigated by using dynamic light scattering measurements, proving that polymer brushes are formed. The particles with surface‐attached initiator are shown to be uniform spherical core‐shell particles by small‐angle neutron scattering measurements.

  相似文献   

96.

Background

Uterine artery embolisation (UAE) has evolved as a minimally invasive and effective alternative, treatment modality for women with symptomatic fibroids. We discuss our initial experience of UAE in the management of symptomatic fibroids.

Methods

Twenty five symptomatic patients of uterine fibroids were treated with UAE by selectively cannulating and injecting poly vinyl alcohol particles into the uterine arteries. Post treatment follow up was done at 2 and 6 months respectively.

Results

Pre-treatment, the sizes of fibroids were between 3.9 and 10.9 cm (mean 7.4) on ultrasonography. Of the total 25 patients, 49 uterine arteries were embolised with a technical success rate of 98%. Menorrhagia persisted in 7 patients, dysmenorrhea in 4 patients and pressure symptoms in 2 patients respectively in follow up study of six months which corresponds to a reduction in symptoms by 68% for menorrhagia, 71% for dysmenorhoea and 75% for those with pressure symptoms respectively. At 2 months follow-up post embolisation, the mean diameter of the fibroid was 4.03 cm (range 2–5.2 cm) and at 6 months 3.2 cm (range 1.3–4.1 cm), corresponding to size reduction of 45.5% and 57%, respectively. Follow up with ultrasonography at 2 and 6 months period showed successful fibroid reduction in 24 patients with corresponding reduction in the symptomatology. One patient remained symptomatic with increase in fibroid size and had to undergo hysterectomy.

Conclusion

Uterine artery embolisation can be considered as an alternative to hysterectomy in appropriately selected symptomatic patients of uterine fibroids.  相似文献   
97.
目的:比较中药复方桑杏颗粒与急支糖浆治疗小儿咳嗽(风热挟痰证)的疗效,探讨复方桑杏颗粒治疗小儿咳嗽的临床应用前景。方法选择某市医院就诊的符合条件的患儿60例,随机分为两组,治疗组(30例)口服桑杏颗粒剂,对照组(30例)口服急支糖浆口服液,两组均以7天为一疗程,观察比较两组的疗效。结果治疗组咳嗽、咯痰症状、肺部听诊体征及胸片改善上均优于对照组。桑杏颗粒治疗小儿咳嗽的效果优于对照组,与急支糖浆相比,其需要治疗人数(NNT)为5人。结论桑杏颗粒剂治疗小儿急性支气管炎疗效显著,临床上值得推广应用。  相似文献   
98.
目的比较磁微粒化学发光试剂与酶联免疫吸咐测定试剂检测戊型肝炎病毒Ig G抗体的结果差异。方法选取企业样本库2010年1月至2012年5月住院和门诊患者935例,分别用A厂家酶联免疫吸咐测定试剂和郑州安图生物磁微粒化学发光试剂测定戊型肝炎病毒Ig G抗体平行检测,不符样本用C厂家酶联免疫吸咐测定试剂复测。结果郑州安图生物磁微粒化学发光试剂和戊型肝炎病毒Ig G抗体A厂家酶联免疫吸咐测定试剂阳性一致百分比为95.5%,阴性一致百分比为97.7%,总符合率为97.2%,差异无统计学意义(P>0.05)。结论磁微粒化学发光戊型肝炎病毒Ig G抗体试剂与酶联免疫吸咐测定试剂临床性能相似,适于临床推广应用。  相似文献   
99.
Correctly folded virus-like particles (VLPs) of papillomavirus (PV) display conformationally dependent epitopes that are type specific, maintained on authentic virions, and induce neutralizing antibodies. Alignment of the L1 amino acid (aa) sequences of 84 PVs revealed that the lengths of their N-termini are diverse and that multiple, possible initiation methionine (met) codons exist. The L1 gene of MusPV (MmuPV1), that naturally infects immunodeficient laboratory mouse strain (NMRI-Foxn1nu/Foxn1nu), has four met codons at the 1st, 2nd, 28th, and 30th aas from its N-terminus. Of these, the 3rd and 4th mets, that are at the 28th and 30th aa position from the N-termius, respectively, are located at the position where most PVs have their first met. These two mets, located at the 9th and 11th from the YLPP conserved aas of most PVs, should be considered as consensus initiation codons of PV L1s. Three L1 proteins of MusPV, starting from the 2nd, 3rd, and 4th mets, were expressed using a baculovirus expression system and characterized for their ability to self-assemble into VLPs. While MusPV L1 proteins starting from the 2nd met expressed an L1 protein that did not fold into VLPs, the L1s starting from the 3rd and 4th mets generated correct VLPs in abundant quantities. We now conclude that the highest quantity and best quality VLPs are made from the consensus L1 met of MusPV.  相似文献   
100.
Kenneth Lundstrom 《Viruses》2014,6(6):2392-2415
Alphavirus vectors have demonstrated high levels of transient heterologous gene expression both in vitro and in vivo and, therefore, possess attractive features for vaccine development. The most commonly used delivery vectors are based on three single-stranded encapsulated alphaviruses, namely Semliki Forest virus, Sindbis virus and Venezuelan equine encephalitis virus. Alphavirus vectors have been applied as replication-deficient recombinant viral particles and, more recently, as replication-proficient particles. Moreover, in vitro transcribed RNA, as well as layered DNA vectors have been applied for immunization. A large number of highly immunogenic viral structural proteins expressed from alphavirus vectors have elicited strong neutralizing antibody responses in multispecies animal models. Furthermore, immunization studies have demonstrated robust protection against challenges with lethal doses of virus in rodents and primates. Similarly, vaccination with alphavirus vectors expressing tumor antigens resulted in prophylactic protection against challenges with tumor-inducing cancerous cells. As certain alphaviruses, such as Chikungunya virus, have been associated with epidemics in animals and humans, attention has also been paid to the development of vaccines against alphaviruses themselves. Recent progress in alphavirus vector development and vaccine technology has allowed conducting clinical trials in humans.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号